B

Bharat Immunologicals & Biologicals Corporation Limited

BIBCL
Market snapshot · 2026-08-12 05:45 UTC

15.75

₹-0.07 (-0.44%)

MARKET CAP

₹68.01 Cr

STOCK P/E

52W HIGH

₹23.19

52W LOW

₹14.10

BOOK VALUE

₹18.24

EPS

₹-3.28

ROE

-21.00%

SECTOR

Health Care

DEBT/EQUITY

94.48

VOLUME

1,516

P/B RATIO

0.86x

PEG RATIO

Sector

Health Care

Themes

PharmaceuticalsPresident of India Portfolio
₹22.63₹20.82₹19.01₹17.19₹15.38VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/S
Strongly Undervalued

5Y Average

15.37

Current

8.89

Overvalued

16.62

Undervalued

12.45

P/B
Undervalued

5Y Average

Current

0.86

Overvalued

0.99

Undervalued

0.73

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.00 CrSep 2023

Latest net profit

₹-4.92 CrSep 2023

Latest EPS

₹-1.14Sep 2023

Net Profit

₹-4.92 CrProfit conversion

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24-60.0%-45.0%-30.0%-15.0%0.0%-9.00 Cr0.00 Cr9.00 Cr18 Cr27 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '240.00 Cr7.00 Cr14 Cr21 Cr28 Cr₹-1₹-1₹-1₹-1₹-1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherOtheradjustmentsNet Profit-12 Cr-9.00 Cr-6.00 Cr-3.00 Cr0.00 Cr

Latest reported period: Sep 2023

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023-75 Cr0.00 Cr75 Cr150 Cr225 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales +25.3625.2015.6214.2224.7017.4322.0410.4826.480.007.650.000.00
Expenses +29.8627.4731.5413.1828.1916.4125.7115.3128.984.7211.674.314.68
Operating Profit-4.50-2.27-15.921.04-3.491.02-3.67-4.83-2.50-4.72-4.02-4.31-4.68
OPM %-17.74%-9.01%-101.92%7.31%-14.13%5.85%-16.65%-46.09%-9.44%-52.55%
Other Income +0.141.209.080.250.220.120.590.140.320.100.490.100.16
Interest1.171.301.221.161.231.541.681.581.741.672.061.722.09
Depreciation0.060.060.060.060.060.040.050.040.040.040.090.030.03
Profit before tax-5.59-2.43-8.120.07-4.56-0.44-4.81-6.31-3.96-6.33-5.68-5.96-6.64
Tax %-30.77%-21.81%-19.46%-2,642.86%105.26%-25.00%-11.02%-20.76%-22.22%-26.07%-31.69%-23.15%-26.05%
Net Profit +-3.87-1.89-6.531.93-9.36-0.33-4.28-5.00-3.08-4.68-3.88-4.59-4.92
EPS in Rs-0.90-0.44-1.510.45-2.17-0.08-0.99-1.16-0.71-1.08-0.90-1.06-1.14
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderMar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters +59.25%59.25%59.25%59.25%59.25%
Public +40.74%40.74%40.75%40.75%40.74%
Others0.01%0.01%0.01%
Mar 2024
Promoters +
Public +
Others

Events Timeline

Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBI'S LODR.

Aug 07, 2024PDFCompany Reports Open

Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBI'S LODR.

Feb 29, 2024PDFCompany Reports Open

Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.

Dec 13, 2023PDFCompany Reports Open

Compliance Of The Regulation Of LODR 2015 For The Intimation Of Book Closure Period (22.12.2023 To 29.12.2023) Of The Company In Respect Of 34Th Annual General Meeting Scheduled To Be Held On 29.12.2023.

Nov 28, 2023PDFCompany Reports Open

Submission Of Notice Of 34Th Annual General Meeting On 29.12.2023 As Compliance Of The Provision Of LODR 2015.

Nov 28, 2023PDFCompany Reports Open